A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongolians

Hepatology

Volumn 66, Issue 6, 2017, Pages 1739-1749

  Chen, Xiaohua ^a,h   Oidovsambuu, Odgerel ^b,c   Liu, Ping ^a   Grosely, Rosslyn ^a   Elazar, Menashe ^a   Winn, Virginia D ^d   Fram, Benjamin ^a   Boa, Zhang ^d   Dai, Hongjie ^d   Dashtseren, Bekhbold ^b,e,f   Yagaanbuyant, Dahgwahdorj ^b,e,f   Genden, Zulkhuu ^b,e   Dashdorj, Naranbaatar ^e   Bungert, Andreas ^e   Dashdorj, Naranjargal ^b,e   Glenn, Jeffrey S ^a,g  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Liver Center   (Mongolia)

^c Mongolian National University   (Mongolia)

^d STANFORD UNIVERSITY   (United States)

^e Onom Foundation   (Mongolia)

^f MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^h SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HEPATITIS B; HEPATITIS DELTA VIRUS; HIGH THROUGHPUT SCREENING; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIXED INFECTION; MONGOLIAN (PEOPLE); PRIORITY JOURNAL; QUANTITATIVE ASSAY; QUANTITATIVE MICROARRAY ANTIBODY ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; CASE CONTROL STUDY; COMPLICATION; DELTA AGENT HEPATITIS; DEVICES; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; ISOLATION AND PURIFICATION; MONGOLIA; PREGNANCY; PREVALENCE; PROCEDURES;

ANTIBODIES, VIRAL; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COINFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MICROARRAY ANALYSIS; MONGOLIA; PREGNANCY; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 85033241002     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28957     Document Type: Article

References (25)

1. Lin HH, Lee SS, Yu ML, Chang TT, Su CW, Hu BS, et al. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program. Hepatology 2015;61:1870-1879.
2. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, et al. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009;136:1629-1638.
3. Heller T, Koh C, Glenn JS. Hepatitis D. In: Sanyal AJ, Boyer T, Terrault N, Lindo K, eds. Zakim and Boyer's Hepatology, 7th ed. New York: Elsevier; 2017;34:1-15.
4. Rizzetto M. Hepatitis D: thirty years after. J Hepatol 2009;50:1043-1050.
5. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011;378:73-85.
6. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004;11:392-398.
7. Hoofnagle JH. Type D (delta) hepatitis. JAMA 1989;261:1321-1325.
8. Olivero A, Smedile A. Hepatitis delta virus diagnosis. Semin Liver Dis 2012;32:220-227.
9. Le Gal F, Brichler S, Sahli R, Chevret S, Gordien E. First international external quality assessment for hepatitis delta virus RNA quantification in plasma. Hepatology 2016;64:1483-1494.
10. Andernach IE, Leiss LV, Tarnagda ZS, Tahita MC, Otegbayo JA, Forbi JC, et al. Characterization of hepatitis delta virus in sub-Saharan Africa. J Clin Microbiol 2014;52:1629-1636.
11. Tabakman SM, Lau L, Robinson JT, Price J, Sherlock SP, Wang H, et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat Commun 2011;2:466.
12. Zhang B, Jarrell JA, Price JV, Tabakman SM, Li Y, Gong M, et al. An integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profiling. PloS One 2013; 8:e71043.
13. Dashtseren B, Bungert A, Dashdorj N. Confirmed high prevalence of hepatitis B and C in Mongolia: a nationwide survey among 1158 Mongolian adults. J Med Virol. Submitted for publication.
14. Glenn JS, Taylor JM, White JM. In vitro–synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol 1990;64:3104-3107.
15. Karatayli E, Altunoglu YC, Karatayli SC, Alagoz SG, Cinar K, Yalcin K, et al. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control. J Clin Virol 2014;60:11-15.
16. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012 [computer program]. Version 1.0. Available at: http://globocan.iarc.fr; 2013.
17. Alves C, Cheng H, Roder H, Taylor J. Intrinsic disorder and oligomerization of the hepatitis delta virus antigen. Virology 2010;407:333-340.
18. Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004;78:2537-2544.
19. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005;150:2513-2528.
20. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005;77:491-499.
21. Tsatsralt-Od B, Takahashi M, Endo K, Agiimaa D, Buyankhuu O, Ninomiya M, et al. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization. J Med Virol 2007;79:1064-1074.
22. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Nymadawa P, et al. Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg 2006;75:365-369.
23. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010;7:31-40.
24. Kushner T, Serper M, Kaplan DE. Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes. J Hepatol 2015;63:586-592.
25. Alcorn T. Mongolia's struggle with liver cancer. Lancet 2011;377:1139-1140.